Is the new pancreatic cancer pill the biggest breakthrough in decades?
by kRasWatch804 votes
Early trial results show a daily pill, daraxonrasib, taken with chemotherapy shrank or cleared tumours in 61% of advanced pancreatic cancer patients, with about one in 12 having no detectable cancer. Experts are calling it a major advance for one of the deadliest cancers, though it's still a small study. Is this the real turning point, or should we wait for bigger trials?
Vote and see results · No sign-up required